Stock NNG NANOGROUP S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company NanoGroup S.A.

Equities

NNG

PLNNGRP00011

Biotechnology & Medical Research

Market Closed - Warsaw S.E.
Other stock markets
 09:25:49 10/05/2024 pm IST 		5-day change 1st Jan Change
1.02 PLN -1.45% Intraday chart for NanoGroup S.A. -0.49% +9.91%
2023 NanoGroup S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 NanoGroup S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Nanogroup SA is a Poland-based company engaged in the biotechnology sector. The Company focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.

Sales per Business

PLN in Million2022Weight2023Weight Delta
Medicines and Other Pharmaceutical Products
100.0 %
0 100.0 % 0 100.0 % -98.55%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
100.0 %
0 100.0 % 0 100.0 % -98.55%

Managers

Managers TitleAgeSince
Tomasz Adam Ciach FOU
 Founder 58 12/16/12
Przemyslaw Daniel Mazurek CEO
 Chief Executive Officer 48 09/17/09
Anna Redwan COO
 Chief Operating Officer - -
Piotr Mierzejewski PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Robert Artur Dziublowski BRD
 Director/Board Member 61 28/21/28
Tadeusz Wesolowski BRD
 Director/Board Member 72 09/17/09
Artur Dariusz Olender BRD
 Director/Board Member 54 19/17/19
Piotr Wojciech Pietrzak BRD
 Director/Board Member 44 17/16/17
Jerzy Garlicki CHM
 Chairman - 28/21/28
Pawel Michal Ciach BRD
 Director/Board Member 55 17/16/17
Przemyslaw Daniel Mazurek CEO
 Chief Executive Officer 48 09/17/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,097,459 17,924,818 ( 89.19 %) 0 89.19 %

Company contact information

NanoGroup SA

ul. Rakowiecka 36

02-532, Warsaw

+48 604 74 13 03

http://www.nanogroup.eu
address NanoGroup S.A.(NNG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
NANOGROUP S.A. Stock NanoGroup S.A.
+9.91% 5.13M
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NNG Stock
  4. Company NanoGroup S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW